BioSpace News Archive

Biotech Bay

OptraSCAN’s Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office.

May 24, 2022
·
2 min read
Biotech Beach

City of Hope to Expand Best-in-Class Supportive Care Program for Cancer Patients, Strengthen Advocacy for the Field With $10 Million Gift From The Sheri and Les Biller Family Foundation

City of Hope, one of the largest cancer research and treatment organizations in the United States and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, has received a $10 million gift from The Sheri and Les Biller Family Foundation.

May 24, 2022
·
8 min read
BioMidwest

Shoulder Surgeons Perform First U.S. Surgeries Using Exactech’s Next Generation Cage Glenoid

Exactech announced successful first surgeries using the Equinoxe® Laser Cage Glenoid, an innovative, next-generation shoulder implant designed to improve glenoid fixation in anatomic total shoulder arthroplasty.

May 24, 2022
·
4 min read
e-clinical Solutions Market Size to Hit US$ 22.7 Billion by 2030

According to Vision Research Reports, the e-clinical solutions market size is expected to hit around US$ 22.7 billion by 2030 and is projected to grow at a registered CAGR of 13.7% during forecast period 2021 to 2030.

May 24, 2022
·
4 min read
Non-alcoholic Steatohepatitis Clinical Trials Market Size to Hit USD 4.1 BN by 2030

According to Vision Research Reports, the non-alcoholic steatohepatitis clinical trials market size is predicted to hit around USD 4.1 billion by 2030, registering a CAGR of 6.4% during the forecast period 2022 to 2030.

May 24, 2022
·
4 min read
Genetown

Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences’ CEO Richard T. Schumacher

Pressure BioSciences, Inc. announced that Emerging Technology Insider, a leading global source for business and financial opportunities of technology companies, has released a new TechTalks video interview featuring Richard T. Schumacher, CEO and Founder of Pressure BioSciences, Inc.

May 24, 2022
·
4 min read
Drug Development

Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in the Phase 3 TRANQUILITY-2 clinical trial of reproxalap in patients with dry eye disease.

May 24, 2022
·
8 min read
Business

PANCRYOS ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR FIRST IN CLASS MACROENCAPSULATION DEVICE

Pancryos today announced that it has executed a global exclusive license with Brigham and Women’s Hospital for the first in class convection-enhanced macroencapsulation device.

May 24, 2022
·
3 min read
Drug Development

Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition

Ocugen, Inc. today announced that it is diversifying its innovative pipeline by introducing a Phase 3, cell therapy platform technology called NeoCart® (autologous chondrocyte-derived neocartilage).

May 24, 2022
·
5 min read
Biotech Beach

Bitech Technologies to Present at the LD Micro Invitational Event on June 8, 2022

Bitech Technologies Corporation today announces that the Company will participate in the upcoming LD Micro Invitational, a prominent 3-day investor conference on June 8, 2022.

May 24, 2022
·
3 min read